Projects per year
- 200 - 250 out of 2,051 results
Search results
-
Active
-
AMADEUS - Double-blind,IMPACT phase III,Randomised Study to Compare the Efficacy and Safety to Oral AZA(CC-486)Versus Placebo in Subject with Acute Myeloid Leukaemia or Myelodysplastic Syndromes as Maintenance after Allogeneic Haematopoieti
Craddock, C., Siddique, S. & Jackson, A.
1/04/18 → 31/03/28
Project: Industry
-
-
CRUK/17/011 FaR-RMS: A multiarm-multistage study for children and adults with localised and metastatic frontline and relapsed RhabdoMyoSarcoma.
Kearns, P., Gatz, S., Liu, W., Gaunt, P., Jackson, A. & Pirrie, S.
Cancer Research Uk, SIOP Europe
1/02/18 → 31/01/28
Project: Research
-
NOSTRA-Feasibility study: A prospective non-randomised multi-centre feasibility study to assess if patients with residual cancer following dual-targeted neoadjuvant chemotherapy treatment for HER2-positive, ER-negative early breast cancer..
Pirrie, S., Rea, D., Gaunt, C. & Billingham, L.
1/01/18 → 31/12/25
Project: Industry
-
CRUK/17/013 E-smart : European proof of concept therapeutic stratification trial of molecular anomalies in replapsed or refractory tumours in children(E-smart)
Kearns, P., Fenwick, N. & Gough, R.
1/11/17 → 28/02/25
Project: Research
-
Investigating the role of protein hydroxylation in cancer
Beggs, A., Stewart, G., Saponaro, M., Higgs, M. & Coleman, M.
1/11/17 → 31/03/25
Project: Research
-
HWB-NMR: a national resource for biomolecular research
Tennant, D., Young, S., Lavery, G., Peet, A., Ludwig, C., Futterer, K., Guenther, U., Henderson, I., Willcox, B., Adams, D. & Carlomagno, T.
25/09/17 → 25/09/24
Project: Research
-
A Phase 2a trial of Avelumab, an anti-PDL 1 antibody, in relapsed and refractory peripheral T-cell lymphoma (AVAIL-T)
Siddique, S., Jackson, A. & Craddock, C.
6/07/17 → 31/12/24
Project: Industry
-
ADAPT SEPSIS - Biomarker-guided duration of antibiotic treatment in hospitalised patients with moderate or severe sepsis
1/05/17 → 31/07/24
Project: Other Government Departments
-
-
Cancer Research UK Birmingham Centre. See Also RCPV20624
Kearns, P., Willcox, B., Lee, S., Middleton, G., Moss, P. & Morton, D.
1/04/17 → 31/12/24
Project: Research
-
Development of a novel repurposed drug treatment for neurodegeneration and diabetes in Wolfram syndrome
Nagy, Z., Peet, A., Brock, K., Barrett, T. & Martin, U.
1/03/17 → 28/02/25
Project: Research Councils
-
The role of tetraspanin CD151 in the biogenesis of the inflammatory breast cancer
THE INFLAMMATORY BREAST CANCER NETWORK UK
1/01/17 → 30/06/24
Project: Research
-
Bladderpath: Image Directed Redesign of Bladder Cancer Treatment Pathways
Ward, D., Bryan, R., Patel, P., Billingham, L. & Pirrie, S.
NIHR EVALUATION, TRIALS AND STUDIES COORDINATING CENTRE
1/10/16 → 30/04/24
Project: Other Government Departments
-
SeluDex: A phase IB/II open label study of the MEK-inhibitor selumetinib in combination with dexamethasone for paediatric and adult patients with 2nd relapsed precursor B- or T-ALL
ASTRA ZENECA UK LIMITED, INNOVATIVE THERAPIES FOR CHILDREN WITH CANCER (ITCC), Cancer Research Uk
1/10/16 → 31/12/24
Project: Research
-
CReST 2 - Colorectal Endoscopic Stenting Trial 2
Handley, K., Deeks, J., Magill, L. & Morton, D.
NIHR EVALUATION, TRIALS AND STUDIES COORDINATING CENTRE
1/07/16 → 30/04/24
Project: Other Government Departments
-
Research work carried out at the Queen Elizabeth hospital on the commercial portfolio
1/04/16 → 31/03/33
Project: Research
-
BIOMEDE : Biological Medicine for Diffuse Intrinsic Pontine Glioma (DIPG) Eradication .
1/02/16 → 30/04/24
Project: Research
-
Assessment of the Mechanism of Action of Venetoclax (ABT-199) in combination with Ibrutinib (PCI-32765) in relapsed/refractory Chronic Lymphocytic Leukaemia (CLARITY)
Brock, K. & Siddique, S.
Janssen-Cilag Limited, Abbvie Ltd, BLOODWISE
1/01/16 → 31/05/24
Project: Research
-
Second International Inter-Group Study for Classical Hidgkins Lymphoma in Children (EuroNet-PHL-C2)
1/11/15 → 31/10/27
Project: Research
-
A phase II trial of MK-3475 in patients with non-small cell lung cancer with a performance status of 2 (PePS2)
Billingham, L. & Middleton, G.
21/10/15 → 31/12/24
Project: Industry
-
Wisteria - Wee inhibitor with Cisplatin and Radiotherapy: A trial in head and neck cancer
Kong, A., Mehanna, H., Parish, J. & Windridge, D.
ASTRA ZENECA UK LIMITED, Cancer Research Uk
1/09/15 → 31/12/24
Project: Research
-
Adjuvant Chemotherapy with Gemcitabine and Cisplatin Compared to Observation After Curative Intent Resection of Cholangiocarcinoma (ACTICCA-1 Trial)
Fox, R., Ma, Y. T. & Stubbs, C.
1/04/15 → 30/11/24
Project: Research
-
CRUK/13/026: CompARE: Phase III randomised controlled trial Comparing Alternative Regimens for escalating treatment of intermediate and high-risk oropharyngeal cancer
Gaunt, P., Billingham, L., Mehanna, H. & Bowden, S.
Cancer Research Uk, ASTRA ZENECA UK LIMITED, CITY HOSPITAL NHS TRUST
1/11/14 → 31/12/25
Project: Research
-
ENDED. OPEN ONLY FOR ARCHIVING AND PUBLISHING COST.Systematic Reviews in Childrens Cancer: CNS Tumours
Wilson, J., Kearns, P. & Wheatley, K.
21/07/14 → 30/04/24
Project: Other Government Departments
-
The Low Risk DCIS (Ductal Carcinoma in Situ) Trial (LORIS)
Billingham, L., Roberts, T., Rea, D., Bowden, S. & Pirrie, S.
NIHR EVALUATION, TRIALS AND STUDIES COORDINATING CENTRE
1/04/14 → 31/03/30
Project: Other Government Departments
-
PHAZAR/RuxAza - A phase Ib study to assess the safety and tolerability of oral Ruxolitinib in combination with 5 azacitidine in patients with accelerated phase MPNs, MDS or AML after MPNs
Siddique, S., Fox, S., Fenwick, N. & Jackson, A.
BLOODWISE, CELGENE INTERNATIONAL SARL, NOVARTIS PHARMACEUTICALS UK LTD
1/04/14 → 31/12/24
Project: Research
-
ROSCO - Response to Optimal Selection of neo-adjuvant Chemotherapy in Operable breast cancer (linked to ROMK17622)
Frew, E., Bowden, S., Rea, D., Billingham, L. & Pirrie, S.
1/09/13 → 31/05/26
Project: Research
-
ROSCO: Response to Optimal Selection of Neo-Adjuvant Chemotherapy in Operable Breast Cancer (linked to RCPV17620)
Frew, E., Billingham, L., Rea, D., Bowden, S. & Pirrie, S.
1/09/13 → 1/04/26
Project: Research
-
A Randomised Phase IIb Trial of BEvACizumab Added to Temozolomide + IrinOtecan for Children with Refractory/Relapsed Neuroblastoma - BEACON Trial
EUSA Pharma (UK) Limited, SOLVING KIDS' CANCER, Cancer Research Uk, INNOVATIVE THERAPIES FOR CHILDREN WITH CANCER (ITCC)
1/01/13 → 30/11/24
Project: Research
-
EME -A Phase II Randomised Clinical Trial of Conditioning Cyclophosphamide and Chemoembiolisation with or without Vaccination with Dendritic Cells Pulsed with HepG2 Lysate in vivo in Patients with Hepatocellular Carcinoma : IMMUNOTACE Trial
Barton, D., Steven, N., Adams, D. & Gough, R.
1/01/13 → 31/12/25
Project: Other Government Departments
-
UKMCC-1 (previously PAZAM!): Pazopanib in Advanced Merkel Cell Carcinoma
Steven, N., Gaunt, P. & Wheatley, K.
Cancer Research Uk, Glaxosmithkline
1/11/12 → 31/12/24
Project: Research
-
International Collaborative Treatment Protocol for Langerhans Cell Histiocytosis (LCH-IV)
1/10/12 → 31/08/24
Project: Research
-
United Kingdom Acute Lymphoblastic Leukaemia Trial 2010 (UKALL2010)
4/10/10 → 30/09/28
Project: Research
-
Axi-STS: A Clinicopathological phase II study of axitinib in patients with advanced angiosarcoma and other soft tissue sarcomas.
Billingham, L. & Hughes, A.
Cancer Research Uk, PFIZER LIMITED
1/06/10 → 31/12/25
Project: Research